This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lovely, L. P. Articles by Lessey, B. A. Search for Related Content PubMed PubMed Citation Articles by Lovely, L. P. Articles by Lessey, B. A. Related Collections Female Endocrinology

Prevention of Endometrial Apoptosis: Randomized Prospective Comparison of Human Chorionic Gonadotropin Versus Progesterone Treatment in the Luteal Phase

Northern California Fertility Medical Center (L.P.L.), Roseville, California 95661; Center for Women’s Health and Reproduction (A.T.F.), Department of Obstetrics and Gynecology, University of Illinois, Chicago, Illinois 60612; Department of Obstetrics and Gynecology (M.A.F.), Division of Human Reproduction and Infertility, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599; Center for Women’s Health (D.G.M.), Oklahoma City, Oklahoma 73120; and Center for Women’s Medicine (B.A.L.), Greenville Hospital System, Greenville, South Carolina 29617

Address all correspondence and requests for reprints to: Bruce A. Lessey, Center for Women’s Medicine, 890 West Faris Road, Suite 470, Greenville, South Carolina 29617. E-mail: blessey{at}ghs.org.

To study control of apoptosis in human endometrium, we examined late luteal-phase endometrial biopsies obtained in the late luteal phase for evidence of apoptosis and compared the effects of exogenous human chorionic gonadotropin (hCG) and progesterone on this process. Using a controlled, prospective, and randomized study design, 12 healthy, fertile, reproductive-age women (ages 20–34 yr) with regular menstrual cycles (range, 26–32 d) were recruited. Each underwent an endometrial biopsy 12 d after a urinary LH surge in a control and treatment cycle. After biopsy in a natural cycle, subjects were randomized to receive luteal doses of either 200 mg intravaginal progesterone (d 18–27) or a single im injection of 10,000 IU of hCG (d 19) followed by repeat endometrial biopsy and collection of serum on d 26. Apoptosis was assessed by DNA laddering, localizing apoptotic bodies using immunofluorescent labeling of DNA fragments (the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling method), and immunohistochemical assessment of apoptosis markers bcl-2, bcl-x, and bax. Serum progesterone levels were compared between treatment groups. Evidence of apoptosis in control cycles was significantly reduced in endometrium after both luteal-phase treatments. The terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling results demonstrated significantly less apoptosis in the hCG treatment group compared with controls. Immunostaining for bcl-2 was higher in hCG- and progesterone-treated cycles, whereas bax expression was decreased and bcl-x immunostaining was not different between treatments. Serum progesterone levels were highest in the hCG-treated group, although statistical significance was not reached (P = 0.08). These results demonstrate that signs of apoptosis, already apparent by d 26 of the menstrual cycle can be reduced with either hCG or progesterone treatment. The clinical utility of these findings includes a rational use of luteal-phase support for treatment of women with infertility and/or recurrent pregnancy loss.

This article has been cited by other articles:

				P. Banerjee, K. Sapru, Z. Strakova, and A. T. Fazleabas Chorionic Gonadotropin Regulates Prostaglandin E Synthase via a Phosphatidylinositol 3-Kinase-Extracellular Regulatory Kinase Pathway in a Human Endometrial Epithelial Cell Line: Implications for Endometrial Responses for Embryo Implantation Endocrinology, September 1, 2009; 150(9): 4326 - 4337. [Abstract] [Full Text] [PDF]

				G. Zimmermann, W. Ackermann, and H. Alexander Epithelial Human Chorionic Gonadotropin Is Expressed and Produced in Human Secretory Endometrium During the Normal Menstrual Cycle Biol Reprod, May 1, 2009; 80(5): 1053 - 1065. [Abstract] [Full Text] [PDF]

				J. R. A. Sherwin, A. M. Sharkey, P. Cameo, P. M. Mavrogianis, R. D. Catalano, S. Edassery, and A. T. Fazleabas Identification of Novel Genes Regulated by Chorionic Gonadotropin in Baboon Endometrium during the Window of Implantation Endocrinology, February 1, 2007; 148(2): 618 - 626. [Abstract] [Full Text] [PDF]

				S. Berndt, S. P. d'Hauterive, S. Blacher, C. Pequeux, S. Lorquet, C. Munaut, M. Applanat, M. A. Herve, N. Lamande, P. Corvol, et al. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium FASEB J, December 1, 2006; 20(14): 2630 - 2632. [Abstract] [Full Text] [PDF]

				P. Cameo, M. Szmidt, Z. Strakova, P. Mavrogianis, K. L. Sharpe-Timms, and A. T. Fazleabas Decidualization Regulates the Expression of the Endometrial Chorionic Gonadotropin Receptor in the Primate Biol Reprod, November 1, 2006; 75(5): 681 - 689. [Abstract] [Full Text] [PDF]

				A. Jasinska, Z. Strakova, M. Szmidt, and A. T. Fazleabas Human Chorionic Gonadotropin and Decidualization in Vitro Inhibits Cytochalasin-D-Induced Apoptosis in Cultured Endometrial Stromal Fibroblasts Endocrinology, September 1, 2006; 147(9): 4112 - 4121. [Abstract] [Full Text] [PDF]

				T. A. Williams, A. Verhovez, A. Milan, F. Veglio, and P. Mulatero Protective Effect of Spironolactone on Endothelial Cell Apoptosis Endocrinology, May 1, 2006; 147(5): 2496 - 2505. [Abstract] [Full Text] [PDF]

				Z. Strakova, P. Mavrogianis, X. Meng, J. M. Hastings, K. S. Jackson, P. Cameo, A. Brudney, O. Knight, and A. T. Fazleabas In Vivo Infusion of Interleukin-1{beta} and Chorionic Gonadotropin Induces Endometrial Changes that Mimic Early Pregnancy Events in the Baboon Endocrinology, September 1, 2005; 146(9): 4097 - 4104. [Abstract] [Full Text] [PDF]